Claire F. Taylor

发表

A mutation hotspot at the p14ARF splice site

J. A. Bishop, D. Bishop, M. Tucker, 2005, Oncogene.

Clinical and molecular phenotype of Aicardi-Goutieres syndrome.

A. Green, D. Bonthron, E. Bertini, 2007, American journal of human genetics.

A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning

G. Taylor, C. Taylor, L. A. Ellis, 2000, Human mutation.

Colorectal Tumors from APC*I1307K Carriers Principally Harbor Somatic APC Mutations outside the A8 Tract

I. Tomlinson, T. Bishop, C. Taylor, 2014, PloS one.

Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012, Clinical Cancer Research.

Human Cancer Biology Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder De fi ned by Integrated Genomic Analysis

C. Taylor, M. Knowles, C. Hurst, 2012 .

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL).

S. Puig, D. Bishop, D. Elder, 2008, European journal of cancer.

Mutation scanning using high-resolution melting.

C. Taylor, Claire F. Taylor, 2009, Biochemical Society transactions.

Spectrum of Phosphatidylinositol 3-Kinase Pathway Gene Alterations in Bladder Cancer

W. Gregory, C. Taylor, M. Knowles, 2009, Clinical Cancer Research.

Current and Emerging Techniques for Diagnostic Mutation Detection

G. Taylor, C. Taylor, Claire F. Taylor, 2004 .

Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection.

G. Taylor, C. Taylor, Claire F. Taylor, 2004, Methods in molecular medicine.

Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.

I. Tomlinson, C. Taylor, S. Hodgson, 2002, The American journal of pathology.

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

C. Taylor, M. Knowles, P. Selby, 2006, Cancer research.

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Olivia Alder, Alastair Droop, Lucy F. Stead, 2017, Cancer cell.

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

W. Gregory, C. Taylor, M. Knowles, 2009, Clinical Cancer Research.

High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material

C. Taylor, D. Bishop, M. Harland, 2019, Scientific Reports.

MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

Ananya Choudhury, D. Bishop, R. Bristow, 2010, Cancer research.

Molecular Profiling in Daily Clinical Practice: Practicalities in Advanced Cholangiocarcinoma and Other Biliary Tract Cancers

C. Taylor, A. Lamarca, J. Valle, 2020, Journal of clinical medicine.

Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler Syndrome

C. Taylor, P. Hawkins, D. Rowczenio, 2019, Arthritis & rheumatology.

Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

A. Harris, P. Ratcliffe, C. Taylor, 2002, Cancer research.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary cancer in clinical practice.

Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes

C. Taylor, M. Knowles, C. Hurst, 2013, Human molecular genetics.

FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma

Adel H Jebar, C. Taylor, M. Knowles, 2005, Oncogene.

In vitro functional effects of XPC gene rare variants from bladder cancer patients

A. Kiltie, M. Churchman, T. Bishop, 2011, Carcinogenesis.

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival.

L. Staudt, A. Rosenwald, W. Chan, 2008, Blood.

Identification of Mutations in Distinct Regions of p85 Alpha in Urothelial Cancer

C. Taylor, M. Knowles, J. Burns, 2013, PloS one.

Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.

C. Taylor, M. Knowles, P. Harnden, 2005, Cancer letters.

Expression of Hypoxia-inducible Factors in Human Renal Cancer : Relationship to Angiogenesis and to the von Hippel-Lindau Gene Mutation 1

A. Harris, P. Ratcliffe, C. Taylor, 2002 .

FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas

C. Taylor, Azzam Ismail, S. Short, 2019, Front. Oncol..

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

J. Malvehy, S. Puig, J. Barrett, 2014, Hereditary Cancer in Clinical Practice.

Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia

J. Malvehy, S. Puig, J. Barrett, 2014 .

CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population

D. Bishop, J. Lubiński, C. Taylor, 2007, Melanoma research.

Cytokine receptor IL27RA is an NF-κB–responsive gene involved in CD38 upregulation in multiple myeloma

P. Giannoudis, U. Klein, D. Westhead, 2023, Blood advances.

Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA‐binding activities

A. Kiltie, C. Taylor, M. Knowles, 2009, Genes, chromosomes & cancer.

Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile, Clinical Outcome and Female Gender Bias in KDM6A Mutation Frequency

Lucy F. Stead, D. Gordenin, L. Klimczak, 2017 .

An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer

C. Taylor, M. Knowles, J. Roulson, 2013, Genes, chromosomes & cancer.

ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death

C. Taylor, S. Lawler, L. Steele, 2013, PloS one.

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma

C. Taylor, P. Selby, R. Banks, 2012, International journal of oncology.

No Evidence for BRAF as a Melanoma/Nevus Susceptibility Gene

D. Bishop, I. Dos Santos Silva, A. Swerdlow, 2005, Cancer Epidemiology Biomarkers & Prevention.

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes

D. Bishop, D. Cox, A. Kiltie, 2011, Carcinogenesis.

Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I β-Tubulin Gene but Changes in Tubulin Isotype Protein Expression

Rosamonde E Banks, C. Taylor, P. Selby, 2005, Clinical Cancer Research.

Prevalence of 9p21 deletions in UK melanoma families

J. Barrett, D. Bishop, C. Taylor, 2005, Genes, chromosomes & cancer.

Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility?

C. Lewis, J. Sanderson, C. Taylor, 2004, Familial Cancer.

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.

Lucy F. Stead, D. Gordenin, L. Klimczak, 2017, Cancer cell.

Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3

J. Fitzgibbon, J. Cavenagh, C. Taylor, 2005, British journal of haematology.

Cancer esearch ical Studies E 11 Expression Is Predictive of Cause-Specific Survival wing Radical Radiotherapy for Muscle-Invasive R der Cancer

D. Bishop, R. Bristow, S. Bhattarai, 2010 .

Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy.

A. Ashworth, J. Peto, O. Fletcher, 2008, Human molecular genetics.

Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: effect on foxp3 and cytokine expression and graft infiltration.

C. Taylor, Chuanming Wang, G. Bishop, 2008, Transplant immunology.

Fungal pathogenesis: Past, present and future

C. Taylor, S. Gurr, Claire F. Taylor, 2014 .